Anikiej P., Mański A., Bidzan M. (2028), Cognitive functioning and autonomy of patients with duchenne muscular dystrophy. Acta Neuropsychol., 16(2), 157–166, doi:10.5604/01.3001.0011.8321.

Anikiej P., Mański A., Bidzan M. (2018), Aktualizacja-siebie rodziców dzieci z dystrofią mięśniową Duchenne’a. Niepełnosprawność – Zagadnienia, Problemy, Rozwiązania, 2(27), 37–53.

Bateson G. (1996), Umysł i przyroda. Warszawa: Państwowy Instytut Wydawniczy.

Baumbusch J., Mayer S., Sloan-Yip I. (2018), Alone in a Crowd? Parents of Children with Rare Diseases’ Experiences of Navigating the Healthcare System. Journal of Genetic Counseling, 28(2), https://www.doi.org/10.1007/s10897-018-0294-9.

Brown S.C., Lucy J.A. (1997), Dystrophin: Gene, Protein and Cell Biology. Cambridge: Cambridge University Press.

Cartoni C., Marino I. (red.) (2010), Dizionario di medicina, Roma: Treccani.

Casiraghi J.L., Bonomi P. (2009), La rete di ascolto DMD: una risorsa per il sostegno del minore affetto da DMD. Raporto finale di ricercha. Roma: Fondazione IARD dal 1961.

Caspi A., Moffitt T. (2006), Gene-environment interactions in psychiatry: Joining forces with neuroscience. Nature Reviews Neuroscience, 7, 583–590, https://www.doi.org/10.1038/nrn1925.

Crisafulli S., Sultana J., Fontana A., Salvo F., Messina S., Trifirò G. (2020), Global epidemiology of Duchenne muscular dystrophy: An updated systematic review and meta-analysis. Orphanet Journal Rare Diseases, 5, 15(1), 141, doi:10.1186/s13023-020-01430-8.

Cuzzocrea F., Larcan R., Westh F. (2013), Family and parental functioning in parents of disabled children. Nordic Psychology, 65(3), 271–287, https://www.doi.org/10.1080/19012276.2013.824201.

Cyrulnik S.E., Fee R.J., DeVino D.C., Goldstein E., Hinton V.J. (2007), Delayed developmental language milestone in children with Duchenne`s muscular dystrophy. The Journal of Pediatric, 474–478, doi: 10.1016/j.peds.2006.12045.

Cyrulnik S.E., Hinton V.J. (2008), Duchenne muscular dystrophy: A cerebellar disorder? Neuroscience and Behavioral Reviews, 32, 486–496, doi:10.1016/ j.neubiorev. 2007.09.001.

Eagle M., Bourke J., Bullock R., Gibson M., Mehta J., Giddings D. (2007), Managing Duchenne muscular dystrophy – the additive effect of spinal surgery and home nocturnal ventilation in improving survival. Neuromuscular Disorders 7(6), 470–475.

Emery E., Muntoni F., Quinlivan R. (2015), Duchenne Muscular Dystrophy. Oxford: Oxford University Press. Emery A.E., Skinner R., Holloway S. (1979) A study of possible heterogeneity in Duchenne muscular dystrophy. Clinical Genetics 15(5), 444–449, doi:10.1111/j.1399-0004.1979.tb01777.x.

Emery A.E. (1984) Genetic heterogeneity in Duchenne muscular dystrophy. Journal of Medical Genetics 21(1), 76–77, doi:10.1136/jmg.21.1.76-b.

Fiez J.A., Petersen S.E., Cheney M.K., Raichle M.E. (1992), Impaired non-motor learning and error detection associated with cerebellar damage. A single case study. Brain 115(1), 155–178, doi:10.1093/brain/115.1.155.

Ghedini P.C., Avellar M.C., De Lima T.C., Lima-Landman M.T., Lapa A.J., Souccar C. (2012), Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice. Brain Research 5(1483), 96–104, doi:10.1016/j.brainres.2012.09.021.

Gowers W.R. (1879), Pseudo-hypertropic Muscular Paralysis – A Clinical Lecture. London: J&A Churchill.

Górecki D., Geng Y., Thomas K., Hunt S.P., Barnard E.A., Barnard P.J. (1991), Expression of the dystrophin gene in mouse and rat brain. Neuroreport: An International Journal for the Rapid Communication of Research in Neuroscience, 2(12), 773–776, https://www.doi.org/10.1097/00001756-199112000-00011.

Hausmanowa-Petrusewicz I. (2005), Choroby nerwowo-mięśniowe. Lublin: PAN.

Hoskin J., Fawcett A. (2014)., Improving the reading skills of young people with Duchenne muscular dystrophy in preparation for adulthood. British Journal of Sociology of Education, 41(2), 172–187, doi:10.1111/1467-8578.12062.

Jorde LB., Carey JC., Bamshad MJ. (2014). Genetyka medyczna (s. 78–79). Wrocław: Elsevier Urban&Partner Kałużewski B. (2014), Genetyka medyczna. Wrocław: Elsevier Urban & Partner.

Kendler K.S., Eaves L.J. (1986), Models for the joint effect of genotype and environment on liability to psychiatric illness. American Journal of Psychiatry, 143(3), 279–289, doi:10.1176/ajp.143.3.279.

Knuesel I., Mastrocola M., Zuellig R.A., Bornhauser B., Schaub M.C., Fritschy J.M. (1999), Short communication: Altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice). European Journal of Neuroscience, 11(12), 4457–4462, doi:10.1046/j.1460-9568.1999.00887.x.

Kopyść Z. (1984), Kompendium zespołów i rzadkich chorób dziecięcych. Warszawa: Wydawnictwo Lekarskie PZWL.

Kozicka A., Prot J., Wasilewski R. (1971), Mental retardation in patients with Duchenne progressive muscular dystrophy. Journal of Neurological Sciences, 14(2), 209–213, doi:10.1016/0022-510x(71)90090-6.

McDonald C.M., Campbell C., Torricelli R.E., Finkel R.S., Flanigan K.M., Goemans N. (2017), Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet, 390(10101), 1489–1498.

Milic Rasic V., Vojinovic D., Pesovic J., Mijalkovic G., Lukic V., Mladenovic J., Kasac A., Novakovic I., Maksimovic N., Romac S., Todorovic S., Savic Pavicecic D. (2014), Intelectual ability in the Duchenne muscular dystrophy and dystrophin gene mutation location. Balcan Journal of Mutation Genetics, 17(2), 25–36, doi:10.2478/bjmg-2014-007.

Plomin R., Davis O.S. (2008), The future of genetics in psychology and psychiatry: microarrays, genomewide association, and non-coding RNA. Journal of Child Psychology and Psychiatry, 50(1–2), 63–71, doi:10.1111/j.1469-7610.2008.01978.x.

Plomin R., Simpson M.A. (2013), The future of genomics for developmentalists. Development and Psychopathology, 25(4), 2, 1263–1278, https://www.doi.org/10.1017/S0954579413000606.

Risch N., Herrell R., Lehner T., Liang K.Y., Eaves L., Hoh J., Griem A., Kovacs M., Ott J., Merikangas K.R. (2009), Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: A meta-analysis. JAMA, 301(23), 2462–2471, doi:10.1001/jama.2009.878

Ryniewicz B. (1997), Choroby nerwowo-mięśniowe. W: Z. Łosiowski (red.) Dziecko niepełnosprawne ruchowo, 46–50. Warszawa: Wydawnictwa Szkolne i Pedagogiczne.

Schara U., Busse M., (2015), Cerebellar-dependent associative learning is preserved in Duchenne muscular dystrophy: A study using delay eyeblink conditioning. Public Library of Science,1–13, doi:10.1371/journal.pone.0126528.

Sekiguchi M., Zushida K., Yoshida M., Maekawa M., Kamichi S., Yoshida M., Sahara Y., Yuasa S., Takeda S., Wada K. (2009), A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice. Brain 132(1), 124–135, doi:10.1093/brain/awn253.

Stawarski A., Szczęsny K., Wojdyło M. (2008), Dziecko z dystrofią mięśniową. W: B. Cytowska, B. Winczura, A. Stawarski (red.), Dzieci chore, niepełnosprawne i z utrudnieniami w rozwoju, 35–38. Kraków: Oficyna Wydawnicza „Impuls”.

Szawłowska G. (1976), Rola rozwoju osobowości w procesie rehabilitacji dziecka z postępującą dystrofią mięśniową Duchenne’a (niepublikowana praca doktorska). Gdańsk.

Van den Borne H.W., van Hooren R.H., van Gestel M., Rienmeijer P., Fryns J.P., Curfs L.M.G. (1999), Psycho-social problems, coping strategies, and the need for information of parents of children with Prader-Willi syndrome and Angelman syndrome. Patient Education and Counseling, 38(3), 205–216, doi:10.1016/s0738-3991(99)00004-x.

Uher R., McGuffin P. (2008), The moderation by the serotonin transporter gene of environmental adversity in the etiology of mental illness: Review and methodological analysis. Molecular Psychiatry, 13(2), 131–146, doi:10.1038/sj.mp.4002067.

US Food and Drug Administration (2016), FDA grants accelerated approval to first drug for Duchenne muscular dystrophy. US Food and Drug Administration (informacja prasowa).

Walker A., Alfonso M.L., Colquitt G., Weeks K., Telfair J. (2016), “When everything changes”: Parent perspectives on the challenges of accessing care for a child with a disability. Disability and Health Journal, 9(1), 157–161, https://www.doi.org/10.1016/j.dhjo.2015.06.002.